GlassScriptPhysician profile
Alexis Schulz
NPI 1699393454
$1,110.05
in general payments reported to CMS, 2019-2025
12 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $227 · 2023: $296 · 2024: $116 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $244.80 | 2023-2024 | Lifevest |
| Biosense Webster, INC. | $213.84 | 2022-2025 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.00 | 2021-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $120.85 | 2023-2025 | Optimizer, Optimizer |
| Medtronic, INC. | $95.51 | 2022-2024 | Micra |
| Abbott Laboratories | $54.27 | 2025 | Mini Trek, Diamondback Coronary |
| E.R. Squibb & Sons, L.L.C. | $50.50 | 2022-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $35.38 | 2025 | |
| Philips North America LLC | $26.55 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Merck Sharp & Dohme LLC | $22.91 | 2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $20.35 | 2025 | |
| Chiesi USA, INC. | $16.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Schulz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.